Format

Send to

Choose Destination
See comment in PubMed Commons below
J Pak Med Assoc. 2015 Nov;65(11 Suppl 3):S100-4.

Effectiveness of platelets rich plasma versus corticosteroids in lateral epicondylitis.

Author information

1
Department of Orthopedic and Trauma PGMI, Hayatabad Medical Complex, Peshawar.
2
Department of orthopedic Gaju Khan Medical College Swabi.

Abstract

OBJECTIVE:

To compare the treatment modalities of lateral epicondylitis in terms of pain relief.

METHODS:

The randomised controlled study was conducted at Hayatabad Medical Complex, Peshawar, Pakistan, from April 2013 to March 2014, and comprised cases of lateral epicondylitis. The patients were selected through consecutive sampling from the outpatient department and were randomly allocated to two equal groups; group A receiving corticosteroid injections, and group B receiving injection of platelet-rich plasma. The patients were followed up for three weeks to determine the effectiveness of intervention.

RESULTS:

The 102 patients in the study were divided into two groups of 51(50%) each. The over mean age was 33.9±10.3 years. Mean age of patients in the corticosteroid group was 34.2±10.2 years and in the other group it was 33.6±10.5 years. Mean baseline visual analogue score in group A were 6.5±1.2 and in group B it was 6.7±1.4. In group A, 74.5% of patients presented in moderate pain category and 25.5% presented in severe pain category. In group B, 70.6% presented in moderate with 29.4% presented in severe pain category. On follow-up, the mean pain score in group A was 4.0±2.6 and in group B it was 3.5±2.61. Group A showed effectiveness in 52.9% patients and group B showed effectiveness in 82.3% (p=0.001).

CONCLUSIONS:

PRP is an effective alternate to corticosteroid in the treatment of lateral epicondylitis (tennis elbow).

KEYWORDS:

Lateral epicondylitis, Tennis elbow, Steroid, Platelet-rich plasma, Visual analogue scale.

PMID:
26878497
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center